Sex difference in hepatic peroxisome proliferator-activated receptor α expression:: Influence of pituitary and gonadal hormones

被引:105
|
作者
Jalouli, M
Carlsson, L
Améen, C
Lindén, D
Ljungberg, A
Michalik, L
Edén, S
Wahli, W
Oscarsson, J
机构
[1] Univ Gothenburg, Dept Physiol & Pharmacol, S-40530 Gothenburg, Sweden
[2] Fac Sci, Inst Biol Anim, CH-1015 Lausanne, Switzerland
关键词
D O I
10.1210/en.2002-220630
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peroxisome proliferator-activated receptor (PPAR) alpha is a nuclear receptor that is mainly expressed in tissues with a high degree of fatty acid oxidation such as liver, heart, and skeletal muscle. Unsaturated fatty acids, their derivatives, and fibrates activate PPARalpha. Male rats are more responsive to fibrates than female rats. We therefore wanted to investigate if there is a sex difference in PPARalpha expression. Male rats had higher levels of hepatic PPARalpha mRNA and protein than female rats. Fasting increased hepatic PPARalpha mRNA levels to a similar degree in both sexes. Gonadectomy of male rats decreased PPARalpha mRNA expression to similar levels as in intact and gonadectomized female rats. Hypophysectomy increased hepatic PPARalpha mRNA and protein levels. The increase in PPARalpha mRNA after hypophysectomy was more pronounced in females than in males. GH treatment decreased PPARalpha mRNA and protein levels, but the sex-differentiated secretory pattern of GH does not determine the sex-differentiated expression of PPARalpha. The expression of PPARa mRNA in heart or soleus muscle was not influenced by gender, gonadectomy, hypophysectomy, or GH treatment. In summary, pituitary-dependent hormones specifically regulate hepatic PPARalpha expression. Sex hormones regulate the sex difference in hepatic PPARalpha levels, but not via the sexually dimorphic GH secretory pattern.
引用
下载
收藏
页码:101 / 109
页数:9
相关论文
共 50 条
  • [41] Peroxisome proliferator-activated receptor α target genes
    Mandard, S
    Müller, M
    Kersten, S
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (04) : 393 - 416
  • [42] Peroxisome proliferator-activated receptor γ and metabolic disease
    Willson, TM
    Lambert, MH
    Kliewer, SA
    ANNUAL REVIEW OF BIOCHEMISTRY, 2001, 70 : 341 - 367
  • [43] The pleiotropic functions of peroxisome proliferator-activated receptor γ
    Debril, MB
    Renaud, JP
    Fajas, L
    Auwerx, J
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2001, 79 (01): : 30 - 47
  • [44] Peroxisome proliferator-activated receptor γ (PPARγ) and sepsis
    von Knethen, Andreas
    Soller, Mathias
    Bruene, Bernhard
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2007, 55 (01) : 19 - 25
  • [45] Peroxisome proliferator-activated receptor γ in diabetes and metabolism
    Rangwala, SM
    Lazar, MA
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (06) : 331 - 336
  • [46] PHYSIOLOGICAL FUNCTIONS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR β
    Neels, Jaap G.
    Grimaldi, Paul A.
    PHYSIOLOGICAL REVIEWS, 2014, 94 (03) : 795 - 858
  • [47] Peroxisome proliferator-activated receptor γ (PPARγ) and sepsis
    Andreas von Knethen
    Mathias Soller
    Bernhard Brüne
    Archivum Immunologiae et Therapiae Experimentalis, 2007, 55 : 19 - 25
  • [48] Evolution of peroxisome proliferator-activated receptor agonists
    Chang, Feng
    Jaber, Linda A.
    Berlie, Helen D.
    O'Connell, Mary Beth
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (06) : 973 - 983
  • [49] Leptin and peroxisome proliferator-activated receptor gamma
    Kim, Y. S.
    Kim, H. H.
    Kang, Y. K.
    Moon, J. S.
    Kwon, S. O.
    Oh, M. K.
    Cha, I. H.
    Kim, S. Y.
    Kim, J. N.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 110 - 110
  • [50] Peroxisome proliferator-activated receptor-γ and lipodystrophy
    Tantsma, Jouke T.
    Rabelink, Ton J.
    FUTURE LIPIDOLOGY, 2006, 1 (04): : 455 - 462